Condition: Lung Cancer, Non-small Cell · Small Cell Lung Cancer · Pleural Mesothelioma · Sponsor: University College, London
TRACERx EVO is a programme of work using a prospective observational cohort study of participants with early- and late-stage non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) and pleural mesothelioma.
This description comes directly from the study's public registry record.
Rachel Leslie · 02031085363 · ctc.tracerxevo@ucl.ac.uk
Aoife Walker · 02031085363 · aoife.walker@ucl.ac.uk
Always discuss trial participation with your own doctor first.
| University College London Hospitals NHS Foundation Trust | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05628376